Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients

Jean-Philippe Jacquin; Cyrus Chargari; Julie Thorin; Dominique Mille; Adrien Mélis; Hubert Orfeuvre; Guillaume Clavreul; Loic Chaigneau; Alice Nourissat; Chantal Dumanoir; Jacqueline Savary; Yacine Merrouche; Nicolas Magné

doi:10.1097/coc.0b013e3182005783

Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e3182005783 ◽

2012 ◽

Vol 35 (1) ◽

pp. 18-21 ◽

Cited By ~ 11

Author(s):

Jean-Philippe Jacquin ◽

Cyrus Chargari ◽

Julie Thorin ◽

Dominique Mille ◽

Adrien Mélis ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Breast Cancer Patients

Download Full-text

Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-005-0116-2 ◽

2005 ◽

Vol 57 (5) ◽

pp. 615-623 ◽

Cited By ~ 17

Author(s):

Alessandra Fabi ◽

Gianluigi Ferretti ◽

Paola Papaldo ◽

Nello Salesi ◽

Mariangela Ciccarese ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Breast Cancer Patients

Download Full-text

Phase II Trial of Pegylated Liposomal Doxorubicin-Cyclophosphamide Combination as First-Line Chemotherapy in Older Metastatic Breast Cancer Patients

Oncology ◽

10.1159/000127411 ◽

2007 ◽

Vol 73 (3-4) ◽

pp. 210-214 ◽

Cited By ~ 8

Author(s):

J.E. Kurtz ◽

F. Rousseau ◽

N. Meyer ◽

T. Delozier ◽

D. Serin ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Breast Cancer Patients ◽

First Line ◽

Line Chemotherapy

Download Full-text

Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-008-0306-9 ◽

2009 ◽

Vol 117 (3) ◽

pp. 591-598 ◽

Cited By ~ 23

Author(s):

Elmar Stickeler ◽

Maximilian Klar ◽

Dirk Watermann ◽

Annette Geibel ◽

Martha Földi ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Multicenter Phase ◽

Line Therapy

Download Full-text

Three-Year Follow-Up of Survival and Progression in a Phase II Trial of Gemcitabine Plus Carboplatin (Plus Trastuzumab in HER2+ Patients) in Metastatic Breast Cancer Patients.

10.1158/0008-5472.sabcs-09-2105 ◽

2009 ◽

Author(s):

D. Loesch ◽

L. Asmar ◽

K. McIntyre ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients

Download Full-text

Abstract OT2-09-01: A multicenter, randomized, phase II trial evaluating the efficacy of eribulin monotherapy and eribulin plus endocrine therapy in locally-recurrent or metastatic breast cancer patients after progression on endocrine therapy (REVERT study)

10.1158/1538-7445.sabcs19-ot2-09-01 ◽

2020 ◽

Author(s):

José Manuel Pérez-García ◽

Alfonso Cortés Salgado ◽

Elena López Miranda ◽

Antonio Antón ◽

Pedro Sánchez Rovira ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Endocrine Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Randomized Phase Ii ◽

Locally Recurrent

Download Full-text

Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1570-7 ◽

2011 ◽

Vol 68 (4) ◽

pp. 1009-1016 ◽

Cited By ~ 2

Author(s):

R. Murialdo ◽

F. Bertolotti ◽

G. Pastorino ◽

M. Mencoboni ◽

M. Bergaglio ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

Her 2

Download Full-text

Non Pegylated Liposomal Doxorubicin Beyond the First Line Treatment of Metastatic Breast Cancer Patients: A Retrospective Analysis

Annals of Oncology ◽

10.1016/s0923-7534(20)32919-7 ◽

2012 ◽

Vol 23 ◽

pp. ix128-ix129

Author(s):

S. Bernhard ◽

L. Mansi ◽

V. Nerich ◽

C.B. Villanueva ◽

E. Dobi ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Line Treatment ◽

Breast Cancer Patients ◽

First Line ◽

First Line Treatment

Download Full-text

Faculty of 1000 evaluation for Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718071081.793483707 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients

Download Full-text

A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.630 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 630-630 ◽

Cited By ~ 4

Author(s):

S. K. Chia ◽

M. Clemons ◽

L. A. Martin ◽

A. Rodgers ◽

K. Gelmon ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Her 2

Download Full-text

A multi-centre phase II trial of pegylated liposomal doxorubicin and trastuzumab in HER-2 over-expressing metastatic breast cancer (MBC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.630 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 630-630 ◽

Cited By ~ 2

Author(s):

S. K. Chia ◽

M. Clemons ◽

L. A. Martin ◽

A. Rodgers ◽

K. Gelmon ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Her 2

Download Full-text